Grant Details

General Overview

Grant Information

Grant name: Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - Clinical Trial Optional)

Funding organization: National Institutes of Health (NIH)

Total funding amount: Up to $275,000

Duration: Maximum of 2 years

Primary objective: To support research on novel screening approaches and therapeutic interventions for genetic conditions detectable through newborn screening.

Key stakeholders: NICHD, researchers, healthcare providers, and newborns.

Funding source: NIH.

Funding type: Grant.

Significance: Addresses critical gaps in newborn screening and early intervention.

Grant frequency: One-time.

Organizational Aspects

Eligible Organization Types

Higher Education Institutions

Public/State Controlled Institutions of Higher Education

Private Institutions of Higher Education

Nonprofits Other Than Institutions of Higher Education

For-Profit Organizations

Small Businesses

Local Governments

State Governments

County Governments

City or Township Governments

Indian/Native American Tribal Governments (Federally Recognized)

Indian/Native American Tribal Governments (Other than Federally Recognized)

Federal Governments

U.S. Territory or Possession

Other: Independent School Districts, Public Housing Authorities, Faith-based Organizations, Regional Organizations, Foreign Organizations.

Scope and Focus

Primary Focus Areas

Development of novel screening approaches and therapeutic interventions for genetic conditions.

Research on conditions currently included in newborn screening panels or those that could benefit from early detection.

Technical Details

Technical Expertise Requirements

Applicants must have the skills, knowledge, and resources necessary to carry out the proposed research.

Financial Structure

Budget Information

Combined budget for direct costs may not exceed $275,000.

No more than $200,000 may be requested in any single year.

Timeline and Implementation

Key Dates

Open Date: January 16, 2025

Application Due Dates: February 16, 2025; June 16, 2025; October 16, 2025; February 16, 2026; June 16, 2026; October 16, 2026; February 16, 2027; June 16, 2027; October 16, 2027.

Expiration Date: November 17, 2027.

Compliance and Requirements

Regulatory Compliance

Applicants must comply with NIH Grants Policy Statement and other federal regulations.

Application Process

Submission Requirements

Applications must be submitted electronically via Grants.gov.

Follow the instructions in the How to Apply - Application Guide.

Grant Details

healthcare research newborn screening genetic disorders clinical trials therapeutic interventions innovation public health
Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - Clinical Trial Optional)
PAR-25-266
NIH Grants
EDU NGO ENTERPRISE PUBLIC RESEARCH OTHER
US
HEALTHCARE OTHER
DEVELOPMENT OTHER
OTHER
SDG3
FUNDING RESEARCH_DEVELOPMENT
None
275000.00
None
275000.00
USD
100.00
June 16, 2027, 10 p.m.
Not specified